Next, we examined the expression of ZAK protein in 140 breast invasive carcinoma samples in a TMA (clinicopathological information is shown in Supplementary Table S3), to determine the extent to which ZAK can be an important factor in determining clinical outcomes of breast invasive carcinoma. Here, MAP3K20 is linked to invasive breast carcinoma.